Heat Stroke
Neurology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Eagle PharmaceuticalsNJ - Woodcliff Lake
1 program1
Dantrolene sodium for injectable suspensionPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Eagle PharmaceuticalsDantrolene sodium for injectable suspension
Clinical Trials (1)
Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)
Start: Sep 2015Est. completion: Oct 2015
Phase 2Completed
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
11h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
11h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
11h ago
Director of Finance
CoMind
London, UK
11h ago
Electronics Engineering Manager
CoMind
London, UK
11h ago
Director of Information Technology
Zavation Medical Products
11h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space